Lunai Bioworks receives first LOI to license next-generation immune cell therapy
Active Biotech to receive US patent for tasquinimod formulation
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
Nuvalent's zidesamtinib NDA filing accepted by US FDA
Hemispherian secures US patent allowance expanding GLIX1 patent protection
AbbVie receives approval for EPKINLY, rituximab and lenalidomide combination
Genentech reports first oral SERD to improve invasive disease-free survival in early breast cancer
Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY
BodyLogicMD supports recommendation to remove black box warnings on certain forms of oestrogen
EirGenix signs second global exclusive licensing deal with Sandoz